191-201 (2003).
2. Lappalainen, K., et al., Cationic liposomes improve
stability and intracellular delivery of antisense
oligonucleotides into CaSki cells. Biochim. Biophys.
Acta, 1196(2), 201-208
Protocols, Volume 2 (A.P.
Cope, ed.). Humana Press (Totowa, NJ), Chapter
15, pp. 201-214 (2007).
6. Guo, R. et al., Cell, 170(6), 1247-1257 (2017).
Trizma is a registered trademark of Sigma-Aldrich Co
Assignment Units Cytokine QC Level Expected Range Units
PDGF-AA 30,000 pg/mL GRO Control 1 105 – 217 pg/mL
Cytokine QC Level Expected Range Units Control 2 501 – 1040 pg/mL
PTEN P7482 Signal Transduction P y n/d y
216 PTEN Clone:PTN-18 P3487 Signal Transduction M y y y
217
SGK (serum and glucorticoid inducible
kinase)
S5188 Signal Transduction P
y n/d n/d
FOLDED USING EASY FOLDING BAG PROCEDURE SOP 6.
00082476SO OR 00089968SO.
DO NOT USE FOAM WHEN PACKAGING THIS ASSEMBLY.7.
PACKAGE XX ASSEMBLIES PER BOX (ITEM 201). IF LOT SIZE IS NOT IN 8.
MULTIPLES OF XX
IgG1κ 100 µg 05-212 $339
Anti-PI 3-Kinase, p85, N-SH2, clone UB93-3 H M R WB IP M IgG 200 µL 05-217 $329
Anti-PI 3-Kinase p85α, clone 8-2D-4D H M R IP IF FC M IgG1 100
) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d
765 Zip Kinase Z0134 1613 DAPK3 P NP_001339.1 y n/d n/d
217 Daxx D7810 1616 DAXX P NP_001135441.1 y y n/d
229 DOPA Decarboxylase D0180 1644 DDC M NP_000781.1,NP
) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d
765 Zip Kinase Z0134 1613 DAPK3 P NP_001339.1 y n/d n/d
217 Daxx D7810 1616 DAXX P NP_001135441.1 y y n/d
229 DOPA Decarboxylase D0180 1644 DDC M NP_000781.1,NP
) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d
765 Zip Kinase Z0134 1613 DAPK3 P NP_001339.1 y n/d n/d
217 Daxx D7810 1616 DAXX P NP_001135441.1 y y n/d
229 DOPA Decarboxylase D0180 1644 DDC M NP_000781.1,NP
14: Propiedades TCP/IP
Instalación y configuración del programa informático y la bomba — 201
6. Hacer clic en ”OK” para guardar las configuraciones y volver a la ventana
“Connection Properties
Elsivier, 2014.
(10) Hospodiuk, M.; Dey, M.; Sosnoski, D.; Ozbolat, I. T. Biotechnol. Adv.
2017, 35, 217–239.
(11) Gong, J.; Schuurmans, C. C. L.; Genderen, A. M. v.; Cao, X.; Li, W.;
Cheng, F.; He, J
Elsivier, 2014.
(10) Hospodiuk, M.; Dey, M.; Sosnoski, D.; Ozbolat, I. T. Biotechnol. Adv.
2017, 35, 217–239.
(11) Gong, J.; Schuurmans, C. C. L.; Genderen, A. M. v.; Cao, X.; Li, W.;
Cheng, F.; He, J
phospho-DAPK (pSer308) D4941 M y n/d n/d
215 DAP Kinase 2 D3191 P y y y
216 Anti Cy3+Cy5 C0992 M NA NA NA
217 Daxx D7810 P y n/d n/d
218 DcR1 D3566 P y y y
219 DcR2 D3188 P y n/d
23604, 13143, 300799 DAPK2,Dapk2 NP_055141.2,NP_034149.2,NP_001013127.1 P y y y
216 Anti Cy3+Cy5 C0992
217 Daxx D7810 13163, 1616 DAXX,Daxx NP_031855.3,NP_001341.1 P y n/d n/d
218 DcR1 D3566 8794 TNFRSF10C
D3191 23604, 13143, 300799 DAPK2,Dapk2 NP_055141.2,NP_034149.2,NP_001013127.1 P y y y
216 Anti Cy3+Cy5
217 Daxx D7810 13163, 1616 DAXX,Daxx NP_031855.3,NP_001341.1 P y n/d n/d
218 DcR1 D3566 8794 TNFRSF10C